BENITEC BIOPHARMA INC. (BNTC) Net margin 2019–2023
BENITEC BIOPHARMA INC. (BNTC) net profit margin by fiscal year — reported net income divided by reported revenue.
-26082.7%FY2023 · since FY2019: 21.4% → -26082.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -26082.7% | -1140.2 pp |
| FY2022 | -24942.5% | -1413.7 pp |
| FY2021 | -23528.8% | -15417.0 pp |
| FY2020 | -8111.8% | -8133.2 pp |
| FY2019 | 21.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice